Search Result "sRAGE."
Increased ACE2, sRAGE, and Immune Activation, but Lowered Calciumand Magnesium in COVID-19
Journal: Recent Advances in Inflammation & Allergy Drug Discovery
Volume: 16 Issue: 1 Year: 2022 Page: 32-43
Author(s): Hussein Kadhem Al-Hakeim,Hawraa Kadhem Al-Jassas
Association Between sRAGE and Arterial Stiffness in Women with Systemic Lupus Erythematosus
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 21 Issue: 3 Year: 2021 Page: 504-510
Author(s): Hongru Wang,Yibin Zeng,Huan Zheng,Bin Liu
The Possible Impact of Hyperuricemia on Serum Soluble Receptor for Advanced Glycation end Products (sRAGE) Levels in Teenagers: A Case Control Study
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 27 Year: 2018 Page: 3232-3239
Author(s): Marta Lemiesz,Edyta Tenderenda-Banasiuk,Dorota Sosnowska,Agnieszka Rybi-SzumiÅska,Justyna Storonowicz,Tomasz Lemiesz,Anna Wasilewska
Kinetics, Role and Therapeutic Implications of Endogenous Soluble form of Receptor for Advanced Glycation end Products (sRAGE) in Diabetes
Journal: Current Drug Targets
Volume: 8 Issue: 1 Year: 2007 Page: 1138-1143
Author(s): Sho-ichi Yamagishi, Takanori Matsui, Kazuo Nakamura
Soluble RAGE-Modulating Drugs: State-of-the-Art and Future Perspectives for Targeting Vascular Inflammation
Journal: Current Vascular Pharmacology
Volume: 8 Issue: 1 Year: 2010 Page: 86-92
Author(s): Niccolo Lanati, Enzo Emanuele, Natascia Brondino, Diego Geroldi
Association of Soluble Receptor for Advanced Glycation End Products Levels with Hypertensive Albuminuria
Journal: Current Vascular Pharmacology
Volume: 13 Issue: 2 Year: 2015 Page: 259-264
Author(s): Huan Zheng,Lingyan Yuan,Nanzi Xie,Huifeng Xu,Xiaoyun Xie,Ming Luo
Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 6 Year: 2017 Page: 937-943
Author(s): Kailash Prasad,Shuchita Tiwari
A Longitudinal Study of Alterations of S100B, sRAGE and Fas Ligand in Association to Olanzapine Medication in a Sample of First Episode Patients with Schizophrenia
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 17 Issue: 5 Year: 2018 Page: 383-388
Author(s): Charilaos Gerasimou,James N. Tsoporis,Nikolaos Siafakas,Erifili Hatziagelaki,Maria Kallergi,Sofia N. Chatziioannou,Thomas G. Parker,John Parissis,Vasileios Salpeas,Charalabos Papageorgiou,Emmanouil Rizos
Soluble Receptor for Advanced Glycation End Products: From Disease Marker to Potential Therapeutic Target
Journal: Current Medicinal Chemistry
Volume: 13 Issue: 1 Year: 2006 Page: 1971-1978
Author(s): Diego Geroldi, Colomba Falcone, Enzo Emanuele
Serum Calprotectin as a Novel Biomarker in Abdominal Aortic Aneurysm Pathogenesis and Progression: Preliminary Data from Experimental Model in Rats
Journal: Current Vascular Pharmacology
Volume: 16 Issue: 2 Year: 2018 Page: 168-178
Author(s): Demetrios Moris,Stamatios Theocharis,Spyridon Davakis,Nikolaos Patelis,Georgios Agrogiannis,Ioannis S. Vlachos,Eleftherios Spartalis,Antonios Athanasiou,Chris Bakoyiannis,Despina N. Perrea,Sotirios Georgopoulos